Delivery Order 36F79719D0224-36C24524N0100
Award Date
10/18/23
Potential Completion Date
10/20/23
Potential Value
$54K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Horizon Therapeutics Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Vergne, TN 37086, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Horizon Therapeutics USA Inc. a firm fixed-price delivery order valued at seventy-one thousand eight hundred eighty-five dollars and sixteen cents ($71,885.16) to provide KRYSTEXXA 8MG. The order was issued against Horizon's Pharmaceuticals and Drugs schedule contract with the General Services Administration. Place of performance will be Horizon's facility located in La Vergne,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a firm fixed price delivery order valued at seventy-one thousand eight hundred eighty-five dollars and sixteen cents ($71,885.16) to Horizon Therapeutics USA Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is to provide KRYSTEXXA 8MG for the treatment period of December 27, 2023 through December 29, 2023 and will be performed in La Vergne,...
The Department of Veterans Affairs Veterans Health Administration awarded Horizon Therapeutics USA Inc. a $107,827 delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is to provide KRYSTEXXA 8MG for use by VHA's Veterans Integrated Service Network 5 based in La Vergne, Tennessee. The firm fixed price order runs from August 24-28, 2023 and will support VHA's mission to provide healthcare services to America's veterans. No subcontractors or set aside...
This delivery order for $55,903.32 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to Horizon Therapeutics USA Inc. against the company's Multiple Award Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The firm fixed price order, with no set-aside designation, is for the medication KRYSTEXXA 8MG and aims to supply VHA hospitals and clinics in La Vergne, Tennessee with this orphan disease treatment through...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Horizon Therapeutics USA Inc. a $71,885 delivery order against the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order is for KRYSTEXXA 8MG to be provided between September 29 and October 3, 2023 at Horizon's facility in La Vergne, Tennessee. The contract utilizes firm fixed pricing and does not appear to include any set-aside designations. ...
The Department of Veterans Affairs Veterans Health Administration awarded Horizon Therapeutics USA Inc. a $89,856 delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is to provide KRYSTEXXA 8MG for use by VHA's Veterans Integrated Service Network 5 based in La Vergne, Tennessee. The firm fixed price order runs from September 20-22, 2023 and will supply the specialty drug to support VHA's healthcare services for veterans in the region. No subcontractors...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $105,097.84 delivery order to Horizon Therapeutics USA Inc. against the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for the drug KRYSTEXXA 8MG and will be fulfilled by the vendor's place of performance in La Vergne, Tennessee by October 16, 2020. No set-aside designation was used for this firm fixed price order to support the VA's healthcare programs.
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $88,713.06 firm fixed price delivery order to Horizon Therapeutics USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for KRYSTEXXA 8MG medication with a completion date of November 17, 2021. Placed against GSA Schedule FSS-61-IB, the delivery order utilizes the pre-competed pricing structure of the multiple award schedule to procure the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $59,142.04 delivery order to Horizon Therapeutics USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for KRYSTEXXA 8MG to support VHA programs, with performance in La Vergne, Tennessee. It has a completion date of December 29, 2021 and was awarded on December 27, 2021. The contract utilizes firm fixed pricing and no set-aside designation.
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $26,274.46 delivery order to Horizon Therapeutics USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule master contract. The delivery order is for the drug KRYSTEXXA and has a completion date of July 31, 2020. Performance will take place in La Vergne, Tennessee. No set-aside designation was used for this award to supply pharmaceutical products to support healthcare...